Sebastian Ruhs is an Infectious Disease physician affiliated with Chase Brexton Health Care. OpenAlex indexes 21 publications with 230 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1111 N Charles St
Baltimore, MD 212015505
Telephone
410-837-2050Registry record last updated 12 Jun 2014.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20257 payments
- Baxter HealthcareProgram year20251 payment
- Gilead Sciences, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
38.4%Statin13.1%Atorvastatin Calcium78%Rosuvastatin Calcium13%Pravastatin Sodium9%Part D<11 patientsCalcium channel blocker7.8%Amlodipine Besylate73%Nifedipine Er27%Part D<11 patients+ 4 more classes in this area
Anti-infectives
21%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor9.4%Tivicay55%Isentress25%Dovato20%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor5%Descovy100%Part D<11 patients+ 3 more classes in this area
Nervous system
16.6%SSRI5.1%Trazodone Hcl45%Citalopram Hbr23%Escitalopram Oxalate16%Sertraline Hcl16%Part D<11 patientsNonsteroidal Anti-inflammatory Drug2%Meloxicam66%Ibuprofen34%Part D<11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- People with HIV Continuing on Complex Regimens in the Era of Treatment Optimization: Characteristics and Outcomes
AIDS Patient Care and STDs
2026 - 505. Real-World Use of Cabotegravir Long-Acting for Pre-Exposure Prophylaxis: Data from Trio Health Cohort
Open Forum Infectious Diseases
2025 - Homelessness and the association with future substance use and STI/HIV risk behaviors among urban gay, bisexual, and other men who have sex with men (MSM): a longitudinal analysis
Journal of Social Distress and the Homeless
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”